Tobi M, Darmon E, Phillips T, Heller T, Rozen P, Nochomovitz L, Steinberg W
Institute of Gastroenterology, Tel Aviv Medical Center, Israel.
Cancer Lett. 1990 May 15;51(1):21-5. doi: 10.1016/0304-3835(90)90226-n.
A monoclonal antibody Adnab-9, was raised against antigens derived from benign polyps of the colon. Adnab-9 was tested against pre-colonoscopic effluent material obtained from groups of patients with a macroscopically normal colonscopic examination, histologically confirmed adenomatous polyps and patients with colorectal cancer (CRC). The resultant binding levels displayed little overlap between the CRC group and the normal, and the difference was statistically significant. Since this putative early neoplasia associated antigen is essentially not expressed in CRC extracts, it may originate from a region of the colon predisposed to neoplasia, increasing in expression as the tendency to malignancy progresses, useful in the diagnosis of early stage malignancy.